Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
5.77
-0.15 (-2.53%)
Dec 5, 2025, 4:00 PM EST - Market closed
Solid Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -167.14 | -124.7 | -96.02 | -85.98 | -72.19 | -88.29 | Upgrade
|
| Depreciation & Amortization | 1.66 | 2.46 | 2.58 | 2.41 | 2.96 | 3.92 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | 0.09 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 3.4 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.93 | -3.59 | -2.41 | 0.23 | 1.12 | -0.02 | Upgrade
|
| Stock-Based Compensation | 14.24 | 10.52 | 7.63 | 7.54 | 13.37 | 11.63 | Upgrade
|
| Other Operating Activities | 12.24 | 9.05 | 2.91 | -18.49 | -0.08 | - | Upgrade
|
| Change in Accounts Receivable | - | - | - | 0.11 | -0.11 | - | Upgrade
|
| Change in Accounts Payable | 4.98 | 2.21 | -0.76 | -5.25 | 1.21 | -3.43 | Upgrade
|
| Change in Unearned Revenue | - | - | - | -8.08 | -12.64 | 20.72 | Upgrade
|
| Change in Other Net Operating Assets | 3.58 | 0.65 | -8.1 | 9.53 | -11.5 | -1.13 | Upgrade
|
| Operating Cash Flow | -132.38 | -100.01 | -94.18 | -97.98 | -77.76 | -56.6 | Upgrade
|
| Capital Expenditures | -0.79 | -0.65 | -1.52 | -3.02 | -1.28 | -0.9 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | 0.01 | - | 0.6 | - | - | Upgrade
|
| Cash Acquisitions | - | - | - | 31.52 | - | - | Upgrade
|
| Investment in Securities | -66.19 | -15.44 | 11.2 | 30.05 | -89.81 | 7.5 | Upgrade
|
| Investing Cash Flow | -66.9 | -16.09 | 9.69 | 59.16 | -91.09 | 6.6 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 2.14 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.47 | - | -0.07 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -0.65 | -0.47 | - | 2.08 | - | - | Upgrade
|
| Issuance of Common Stock | 198.57 | 128.02 | 3.12 | 72.75 | 134.99 | 132.49 | Upgrade
|
| Other Financing Activities | -1.68 | -5.11 | - | - | - | -3.79 | Upgrade
|
| Financing Cash Flow | 196.24 | 122.44 | 3.12 | 74.83 | 134.99 | 128.7 | Upgrade
|
| Net Cash Flow | -3.04 | 6.34 | -81.37 | 36.01 | -33.87 | 78.7 | Upgrade
|
| Free Cash Flow | -133.17 | -100.67 | -95.7 | -100.99 | -79.05 | -57.5 | Upgrade
|
| Free Cash Flow Margin | - | - | - | -1247.74% | -580.36% | - | Upgrade
|
| Free Cash Flow Per Share | -1.79 | -2.47 | -4.81 | -11.87 | -11.11 | -16.61 | Upgrade
|
| Levered Free Cash Flow | -77.4 | -56.21 | -64.71 | -45.32 | -40.95 | -34.85 | Upgrade
|
| Unlevered Free Cash Flow | -77.35 | -56 | -64.43 | -45.32 | -40.95 | -34.85 | Upgrade
|
| Change in Working Capital | 8.56 | 2.85 | -8.87 | -3.69 | -23.04 | 16.16 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.